MBBS, FRCA, FRCP, FJFICM
Charlie is a Senior Intensive Care Specilaist at University Hospital Geelong, and the President of the College of Intensive Care Medicine
He undertook medical training at St Bartholomew’s hospital in London. After training as a physician he converted to anaesthesia and finally settled on becoming an intensive care specialist. After working in Hong Kong he came to Australia, initially working as Director of Intensive Care at the Repatriation Hospital in Melbourne. In 1991 he became Director of Intensive Care in Geelong. He has had extensive invovlement with the College of Intensive Care Medicine, serving as an Examiner, and an Executive Member since 2003. In 2008 he stepped down as Director of ICU at UHG to concentrate on his diverse medical interests.
Charlies careers include;
- Former President of the College of Intensive Care Medicine
- Regional clinical lead for the Respecting Patient Choices program
- Originator of the ‘MyValues’ approach to advance care planning
- Former Director ICU, Bawon Health
Charlie has published a number of papers and books on medicine and was featured on the ABC in the film ‘In the End’, and 'Insight'.
Respecting Patient Choices
Latest news:
-
Thursday, December 23, 2021 - 16:40
JAMA: RCT of calcium chloride (IO or IV) delivered during OHCA was not superior to N.S in terms of sustained return of spontaneous circulation, or longer term outcomes. Although not reaching statistical significance, and the caution required when interpreting results of a trial stopped early, calcium was associated with worse outcomes
Thursday, December 23, 2021 - 14:51JAMA BOUGIE Trial bougie as ETT introducer not superior to stylet for first pass intubation success in critically ill adults in a cohort of predominantly ER physician operators with median experience of 60 intubations. Surprisingly, and difficult to plausibly attribute causation, trend with bougie to improved short-term cardiovascular outcomes, decreased ICU LOS and increased ventilator free days.
Thursday, December 23, 2021 - 13:57JAMA COVID: Open label RCT comparing HFNC to conventional oxygen in adult patients with severe COVID reported HFNC associated with significant improvement in terms of the need for intubation, 28-day clinical recovery, and 28-day VFDs
Wednesday, December 22, 2021 - 13:02JAMA COVID ECMO: Overall this thoughtful and expert viewpoint offers a response to the data reporting increasing duration and mortality of ECMO observed during COVID, in the absence of comparator and baseline data to allow us to elucidate reasons. 1. Regular review candidacy criteria and outcomes 2. Optimise regional capability 3. Robust trials. Understanding the best place for ECMO in the COVID algorithm is yet to be determined
Tuesday, November 23, 2021 - 17:59JAMA Viewpoint - “How will we know if we succeed?”. How can we progress the efficacy of physician wellbeing, if we only measure major outcomes - patient mortality and physician burnout. We need to add and validate intermediate outcome measures, and this viewpoint makes the case beautifully.